karlschnell

Brenntag Specialties announces exclusive distribution agreement with Pathway Intermediates for 'Lipidol' Animal Nutrition supplements in Europe

brenntag• This agreement is the next step in the successful cooperation between Brenntag and Pathway Intermediates • Customers in the Animal Nutrition and Pet Food industries are provided with full access to the Lipidol range • Pathway Intermediates solutions meet the growing demand for precision nutrition

Brenntag, the global market leader in chemicals and ingredients distribution, today announced a new and exclusive distribution agreement between Brenntag Animal Nutrition and Pathway Intermediates, the leading European manufacturer of absorption enhancer in Animal Nutrition.

Brenntag Pathway

The agreement is for the distribution of Lipidol, the first absorption accelerator for the Animal Nutrition industry in Central and Eastern Europe (CEE), Benelux and Nordic.

The Lipidol range, the world's first absorption accelerator, contains highly concentrated functional Lysophopholipids. Lipidol accelerates nutrient absorption, thereby enhancing livestock performance and minimizing nutrient and energy losses in the feed. This new agreement is the next step building on the extensive experience gained in the cooperation between the companies in CEE with the Lipidol range since 2014.

Wouter Vullings, Director Brenntag Animal Nutrition EMEA, states: "We are looking forward to expanding our long-term collaboration in CEE towards the Benelux and Nordic region. Pathway Intermediate's Lipidol range complements Brenntag's existing Animal Nutrition portfolio of performance enhancers. This agreement supports our long-term strategic goal to expand our presence as a leading Animal Nutrition solutions and ingredient supplier in the Animal Nutrition and Pet Food industries in the EMEA region."

Edward Youngman, CEO Pathway Intermediates, says: "This extended partnership will allow Pathway Intermediates to expand its footprint to full market coverage in these key regions and efficiently serve a number of new customers through the dedicated Brenntag team. Joining forces in this way has been a successful journey in CEE already, we look forward to a fruitful continuation and expansion of our cooperation that will benefit both parties and their customers."

About Pathway Intermediates:

Pathway Intermediates was founded in 2001 in the UK and acquired by EASY BIO of Korea in 2016.  EASY BIO was founded in 1988 and has a turnover of EUR 3 billion. With operations spanning from farm to fork the group continues to expand its footprint in Asia, Europe and North America.  Pathway Intermediates is the global animal nutrition brand of EASY BIO and is dedicated to research and development and the science of feeding tomorrow.

About Brenntag:

Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,700 employees worldwide and operates a network of about 600 sites in 72 countries. In 2023, Brenntag generated sales of 16.8 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, in the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 50 ESG and DAX ESG Target. For more information, visit www.brenntag.com